Welcome : Guest

ThromboGenics N.V. (Belgium) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about ThromboGenics N.V., which is principally involved in the Manufacture and Distribution of Biopharmaceuticals. Illustrated with 46 tables, the report showcases the company's recent news stories and events, sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-12328
Price: $2300
Company Type: Public
Pages: 49
Date: October 2015
Market Data Tables: 46

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: ThromboGenics N.V.’s Sales by Geographic Region Worldwide (2013-2014) in Percentage for United States, European Union, Rest of the World and Others......3
Biopharmaceuticals......4
Table 2: Biopharmaceuticals Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Asia, Africa and Australia, Europe, US and Others......4
Table 3: Pharmaceutical Drugs Market by Category in Germany (2014) - Percentage Share Breakdown by Value Sales for Biopharmaceuticals, Pharma Drugs for Human Use, and Others......5
Table 4: Proteins Market by Segment in China (2014) - Percentage Share Breakdown by Value for Erythropoietin (EPO), Granulocyte Colony Stimulating Factor (GCSF), Insulin, Interferon, Interleukin, Monoclonal Antibody (MAb), Nerve Growth Factor (NGF), and Somatropin......6
Table 5: Drugs Market by Category Worldwide (2014) - Percentage Share Breakdown by Value for Biologics, and Chemicals......7
Table 6: Drugs Market by Category Worldwide (2015)-Percentage Share Breakdown by Value for Biologics, Monoclonal Antibodies and Other Classes......8
Table 7: Pharmaceuticals Market by Therapeutic Area in China (2015) - Percentage Share Breakdown by Value for Alimentary Tract and Metabolism, Blood and Blood Forming Organs, Cardiovascular System, Nervous System, Oncology and Immunomodulating Agents, Systemic Anti-infectives, Musculo-Skeletal System and Others......9
Biologics......10
Table 8: Biological Drugs Market by Product Segment Worldwide (2015) - Percentage Share Breakdown by Value for Daratumuma, Elotuzumab, MOR202 and SAR650984......10
Table 9: Biologics Therapeutic Classes Market by Category in China (2014) - Percentage Share Breakdown by Value for Cardiovascular, CNS, Dermatology, Hematology, Metabolic, Musculoskeletal, Oncology, Urinary, and Others......11
Table 10: Therapeutic Biologics Market by Type in China (2014) - Percentage Share Breakdown by Value for Erythropoietin (EPO), Granulocyte Colony-Stimulating Factor (GCSF), Insulin, Interferon, Interleukin, Monoclonal Antibodies (MAb), Nerve GF, Somatropin, and Others......12
Table 11: No. of Biologics in Development by Therapeutic Area Worldwide (2014) - Percentage Market Share Breakdown for Autoimmune Disorders, Blood Disorders, Cancer/ Related Conditions, Cardiovascular Disease, Diabetes/Related Conditions, Digestive Disorders, Eye Conditions, Genetic Disorders, Infectious Diseases, Musculoskeletal Disorders, Neurologic Disorders, Respiratory Disorders, Skin Diseases, Transplantation, and Others......13
Table 12: Injectables Market by Segment Worldwide (2015)-Percentage Share Breakdown by Value for Biologics, Standard Injectablmes, Vaccines and Others......14
Table 13: Injectable Products Market by Type in Europe (2014) - Percentage Breakdown by Value Sales for Biologics, Biosimilars, Branded Injectables and Generic Injectables......15
Table 14: Dermatology Biologics Market by Product Type Worldwide (2014) - Percentage Share Breakdown by Value Sales for ENBREL, HUMIRA, REMICADE, and STELARA......16
Table 15: Rheumatology Drugs Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Biologicals, Coxibs, NSAIDs, TNF Inhibitors, and Others......17
Table 16: Rheumatology Drugs Market by Product Type in the US (2014) - Percentage Share Breakdown by Value Sales for Biologicals/TNF Inhibitors, Coxibs, DMARDS, Gout, MuscleRelaxants, NSAIDS, and Others......18
Table 17: Orthopedics Market by Category Worldwide (2014) - Percentage Share Breakdown by Volume Sales for Biologics, CMF, Dental Implants, Extremities, Hips, Knees, Spine, Sports Medicine, and Trauma......19
Biosimilars......20
Table 18: Biosimilars Market by Segment Worldwide (2014) - Percentage Share Breakdown by Value for Erythropoietin (EPO), Filgrastim, New Biosimilars, and Somatropin......20
Branded Stimulant Drugs......21
Table 19: Branded Stimulant Drugs Market by Prescription Worldwide (2015)-Percentage Share Breakdown by Value for Adderall XR, Focalin XR, Vyvanse and Others......21
GLP-1 based Drugs......22
Table 20: GLP-1 Sales by Category in the US (2014) - Percentage Market Share Breakdown by Value for Byetta/Bydureon (AZN), Lixisenatide (SNY), and Victoza (NovoNordisk)......22
Oncology......23
Table 21: Oncology Drug Market by Region Worldwide (2015)-Percentage Share Breakdown by Value for European Union Five, Japan, US and Others......23
Table 22: Oncology Market by Category in China (2015)-Percentage Share Breakdown by Value for Anti- Tumor Agents, Hormone Therapy, Immuno Suppresants and Immunostimulants......24
Table 23: Oncology/Hematology Drugs Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Blood Cell Factors, Chemopreventatives, Chemotherapeutics, Mabs, Targeted Therapies, and Others......25
Diabetes Drugs......26
Table 24: Diabetes Drug Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for DPP-4 Inhibitor, GK Activator, GLP-1 Agonist, GPCR Agonist, IL- Receptor Antagonist, Insulin Analogue, PPAR Agonist, SGLT-2 Inhibitor, and Others......26
Table 25: Diabetes Drugs Market by Product Category in China (2015) - Percentage Share Breakdown by Value for Acarbose, Insulin, Melbine, and Other Diabetes Drugs......27
Table 26: Diabetes/Metabolic Drugs Market by Category Worldwide (2014) - Percentage Breakdown by Value Sales for DPP-IV Inhibitors, Glitazones, GLP-1 Analogs, Insulins, Sulfonylureas, and Others......28
Table 27: Antidiabetes Molecules Market by Drug Worldwide (2015)-Percentage Share Breakdown by Value for Metformin, Sulfonylureas, Thiazolidin Ediones and Others......29
Table 28: No. of Diabetes Patients by Medication in the US (2014) - Percentage Share Breakdown for Insulin and Oral Medication, Insulin Only, No Medication, and Oral Medication Only......30
Therapeutic Drugs......31
Table 29: Therapeutic Drugs Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Cancer/Onc./Hem., Cardiology, CNS, Dermatology, Diabetes, GI/Ulcer, Infectious Disease, Multiple Sclerosis, Ophthalmology, Respiratory, Rheumatology, Women's Health, and Others......31
Table 30: Therapeutics Market by Segment Worldwide (2014) - Percentage Share Breakdown by Value Sales for Antidiabetics, Asthma/COPD, Autolmmune, Lipid Regulators, Oncologicsm, and Others......32
Biopharmaceuticals......33
Table 31: Market Shares of Leading Biopharmaceutical Companies Worldwide (2014) - Percentage Breakdown by Volume (Installed Capacity) for Amgen Inc., Biogen Idec, Inc., Bristol-Myers Squibb Company, C.H. Boehringer Sohn AG & Co. KG, Eli Lilly and Company, F. Hoffmann-La Roche Ltd, Johnson & Johnson Ltd., Lonza Group Ltd, Pfizer, Inc., Sanofi S.A., and Others......33
Table 32: Market Shares of Leading Erythropoietin (EPO) Companies in China (2014) - Percentage Share Breakdown by Value for 3SBio, Inc., Beijing Four Rings Biopharmaceutical Co, Ltd., Kyowa Hakko Kirin Co, Ltd., North China Pharmaceutical Group Corporation, Shanghai Fosun Pharmaceutical Group Co, Ltd., and Others......34
Table 33: Market Shares of Leading Generic Injectable Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Fresenius SE & Co., Hikma Pharmaceuticals, Hospira, Inc., Luitpold Pharmaceuticals, Inc. and Others......35
Table 34: Market Shares of Leading Therapeutic Providers (Alzheimer's Disease, Bone Diseases, Cardiology, CNS, Dermatology, Diabetes/Metabolic, Epilepsy, G.I./Ulcer, HBV/HCV, Infectious Disease, Multiple Sclerosis, Obesity, Onc./Hematology, Ophthalmology, Orphan Disease, Pain Management, Respiratory, Rheumatology, Sleep Disorders, Urinary Incont., and Women's Health) by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Amgen, Inc., AstraZeneca Plc, Biogen Idec, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Endo International Plc, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Novo Nordisk A/S, Pfizer, Inc., Sanofi S.A., and Others......36
Bio Contract Manufacturing Organizations (CMO)......37
Table 35: Market Shares of Leading Bio- Contract Manufacturing Organization (CMO) Operations Worldwide (2015) - Percentage Breakdown by Volume for C.H. Boehringer Sohn AG & Co. KG, Celltrion, Lonza Group, Samsung Biologics, and Others......37
Biosimilars......38
Table 36: Market Shares of Leading Biosimilar Drug Producing Companies in Europe (2015)-Percentage Share Breakdown by Value for Hospira, Inc., Sandoz, Teva Pharmaceuticals Industries Ltd. and Others......38
GLP-1 based Drugs......39
Table 37: Market Shares of Leading Drug Sales for GLP-1 based Diabetes Worldwide (2014) - Percentage Breakdown by Value for Albilgutide, Bydureon, Byetta, Dulaglutide, Lixumia and Victoza......39
Insulin......40
Table 38: Market Shares of Leading Insulin Companies in China (2015)-Percentage Share Breakdown by Volume for Novo Nordisk, Tonghua Dongbao Pharmaceutical Co., Ltd., Wanbang Biopharmaceuticals Co., Ltd. and Others......40
Nerve Growth Factor (NGF)......41
Table 39: Market Shares of Leading Nerve Growth Factor (NGF) Companies in China (2014) - Percentage Share Breakdown by Value for Ningbo Hi-Tech Biochemicals Co, Ltd., Staidson (Beijing) Biopharmaceuticals Co, Ltd., Xiamen Bioway Pku Co, Ltd., and Others......41
Diabetes Drugs......42
Table 40: Market Shares of Leading Diabetes Care Companies Worldwide (2014) - Percentage Breakdown by Value Sales for Bristol-Myers Squibb (Incl Amylin), Eli Lilly and Company, Merck & Co., Inc., Novo Nordisk A/S, Sanofi S.A. and Others......42
Table 41: Market Shares of Leading Diabetes Drugs Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Novo Nordisk A/S, Pfizer, Inc., Sanofi S.A., and Others......43
Oncology Drugs......44
Table 42: Market Shares of Leading Oncology Drug Manufacturers in China (2015)-Percentage Share Breakdown by Value for Astrazeneca, Jiangsu Hengrui Medicine Co., Ltd., Roche Group and Others......44
Table 43: Market Shares of Leading Oncology/Hematology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Amgen, Inc., AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......45
Table 44: Market Shares of Leading Oncology Product Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Fresenius SE & Co., and Others......46
Ophthalmology Therapeutics......47
Table 45: Market Shares of Leading Ophthalmology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for F. Hoffmann-La Roche AG, Merck Ltd., Novartis AG, Pfizer, Inc., and Others......47
Table 46: Market Shares of Leading Ophthalmic Steroids Brands in the US (2015)-Percentage Share Breakdown by Value for Fluorometholone, Lotemax, Prednisolone and Others......48